Background: Pathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP consultations and emergency presentation. This is the first qualitative study to examine events leading to diagnosis by asking patients about their experiences during this time. Methods: Set within a UK population-based cohort, semi-structured interviews were conducted with 20 myeloma patients with varying characteristics and pathways, 12 of whom invited their relatives to take part. Interviews were audio-recorded and qualitative analysis undertaken. Results: Pre-diagnostic awareness of myeloma was minimal. Disease onset was typically described as gradual, and health changes vague but progressive, with increasing loss of function. A wide rang...
Background Multiple myeloma is a type of blood cancer which starts at the bone marrow. Fifty percent...
Aim To explore patients’ lived experience of being diagnosed with myeloma. Method A hermeneutic...
BACKGROUND: UK policy aims to improve cancer outcomes by promoting early diagnosis, which for many h...
BACKGROUND: Pathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP co...
© 2018 Howell et al. This is an open access article distributed under the terms of the Creative Comm...
BackgroundPathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP cons...
ObjectivesTo explore alignment of experiences before lymphoma and myeloma diagnosis with the apprais...
OBJECTIVES: To explore alignment of experiences before lymphoma and myeloma diagnosis with the appra...
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. Objectives ...
© 2013 Howell et al. Background: Prior to diagnosis, patients with haematological cancers often have...
This is the author accepted manuscript. The final version is available from Royal College of General...
Simple Summary: Myeloma, a blood cancer, is rare and hard to diagnose. People often suffer irreversi...
Prompt cancer diagnosis may align UK survival with European averages. We examined the impact of rout...
Prompt cancer diagnosis may align UK survival with European averages. We examined the impact of rout...
haematological malignancy with reported mortality of 10–20 % within the first 2 months of presentati...
Background Multiple myeloma is a type of blood cancer which starts at the bone marrow. Fifty percent...
Aim To explore patients’ lived experience of being diagnosed with myeloma. Method A hermeneutic...
BACKGROUND: UK policy aims to improve cancer outcomes by promoting early diagnosis, which for many h...
BACKGROUND: Pathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP co...
© 2018 Howell et al. This is an open access article distributed under the terms of the Creative Comm...
BackgroundPathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP cons...
ObjectivesTo explore alignment of experiences before lymphoma and myeloma diagnosis with the apprais...
OBJECTIVES: To explore alignment of experiences before lymphoma and myeloma diagnosis with the appra...
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. Objectives ...
© 2013 Howell et al. Background: Prior to diagnosis, patients with haematological cancers often have...
This is the author accepted manuscript. The final version is available from Royal College of General...
Simple Summary: Myeloma, a blood cancer, is rare and hard to diagnose. People often suffer irreversi...
Prompt cancer diagnosis may align UK survival with European averages. We examined the impact of rout...
Prompt cancer diagnosis may align UK survival with European averages. We examined the impact of rout...
haematological malignancy with reported mortality of 10–20 % within the first 2 months of presentati...
Background Multiple myeloma is a type of blood cancer which starts at the bone marrow. Fifty percent...
Aim To explore patients’ lived experience of being diagnosed with myeloma. Method A hermeneutic...
BACKGROUND: UK policy aims to improve cancer outcomes by promoting early diagnosis, which for many h...